CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Shares withheld for taxes President and CEO gave up 83,305 shares (to pay taxes)
- 4 Gift 10% owner gave 40,000 shares (gift)
- 4 Open-market sale Chief Operating Officer sold 44 shares at $4.87 ($214)
- 4/A Shares withheld for taxes Chief Innovation/Tech Officer gave up 9,645 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Science Officer gave up 19,505 shares (to pay taxes)
- 4/A Shares withheld for taxes President and CEO gave up 56,824 shares (to pay taxes)
- 4/A Shares withheld for taxes SVP, Operations gave up 14,120 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 10,819 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Grant or award SVP Sales and Marketing acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Science Officer acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 5 of 17 · 326 filings